Lung Cancer

CAESAREA, Israel , Dec. 2, 2021 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) (TASE: ICCM) ("IceCure" or the "Company"), developer of minimally-invasive cryoablation technology, the ProSense ® System, that destroys tumors by freezing as an alternative to surgical tumor removal, today announced that interim data from the ICE3 Clinical Trial on cryoablation of small, low-risk breast cancer was featured by Co-Primary Investigator, Dr. Kenneth Tomkovich at the Radiologists Society of North America (RSNA), which was held from November 29 th through December 2 nd .  Dr. Tomkovich's presentation, "Primary Treatment of Low Risk Breast Cancers Using Image-Guided Cryoablation: A 6 Year Update of the ICE3 Trial" was selected to be featured in a daily bulletin by RSNA, the largest radiology society in the world with over 48,000 members in the United States , representing 31 radiologic sub-specialties sharing state-of-the-art ra

Hugh Jackman has a history of skin cancer on his nose, so when he had another irregular spot biopsied recently, the actor posted a video reminder urging everyone to get regular skin checks and wear sunscreen. The "Wolverine" star, 52, said in a video posted on Monday that he just left a visit with his dermatologist and pulled down his mask to show a bandage over his nose. "They saw something that was a little irregular, so they took a biopsy, getting it checked," Jackman said. "So if you see a shot of me with this on, do not freak out. Thank you for your concern." Jackman said he would update fans if there's an issue with the spot, but said the doctors think this one is "probably fine." "But just remember: go and get a check and wear sunscreen. Don't be like me as a kid. Just wear sunscreen." said Jackman, who grew up in Australia with plenty of sunny beach days. Over the years, Jackman has reminded fans about the dangers of get

Leukemia is a type of cancer that starts in the blood-forming tissues of the bone marrow. There are a number of symptoms of leukemia, one of which is skin changes that look like rashes. The rashes can differ in appearance, depending on the type. They may be a symptom of the cancer itself or a side effect of treatment. This article discusses the types of rashes that can appear with leukemia and the treatment options available. FatCamera / Getty Other Symptoms of Leukemia The bone marrow in our bodies creates cells that develop into white blood cells, red blood cells, and platelets. With leukemia, the bone marrow produces too many abnormal white blood cells. These faulty cells crowd out the healthy ones and make it hard for them to function properly. Unlike other types of cancer, leukemia usually doesn't form into a tumor that can be seen on imaging tests. There are several types of leukemia, which are categorized by the blood cells they aff

By engaging with others who are managing similar concerns, you're able to get another perspective and in some cases more options to deal with the issue in front of you. For instance, if you're trying to figure out how to deal with erectile dysfunction, group members can tell you what worked for them. "Men often like talking with other men who have prostate cancer and online support groups are one way to connect," says Terry A. Badger, Ph.D., R.N., a member of the Cancer Prevention and Control Program at the University of Arizona Cancer Center in Tucson, AZ.

D. Ross Camidge, MD, PhD, and Alexander I. Spira, MD, PhD, discussed the use of NRG1 fusions as being a driver for patients with lung cancer. Data regarding clinical, pathologic, and molecular features of NRG1 fusion–positive lung cancers are relatively limited given the rarity of NRG1 aberrations and their recent discovery in this tumor type. 1-3 With NRG1 fusions first discovered in lung cancers in 2014, 4 limited data exist on tumors harboring these oncogenes. Therefore, effectiveness of systemic therapies to treat patients with NRG1 fusion–positive lung cancers is also limited when compared with other lung cancer subtypes. In a recent Between the Lines presentation hosted by CancerNetwork®, D. Ross Camidge, MD, PhD , and Alexander I. Spira, MD, PhD , discussed details from the eNRGy1 Global Multicenter Registry, which sought to contribute pertinent data to a central registry on patients with NRG1 fusion–positive lung cancers. "Here we are in the 21st century and we are

The most effective treatment strategy—adjuvant, neoadjuvant, or some combination of adjuvant plus neoadjuvant regimens— remains unclear. Ongoing trials are dedicated to defining the best sequence of treatment. Immunotherapy remains breakthrough in the treatment of cancer in recent years, and the emergence of immune checkpoint inhibitors (ICIs) such as PD-L1/PD-1 and CTLA-4, especially in lung cancer, has resulted in improved outcomes in patients. Historically, the ICIs atezolizumab (Tecentriq), durvalumab (Imfinzi), ipilimumab (Yervoy), nivolumab (Opdivo), and pembrolizumab (Keytruda) have gained standard of care status in early and metastatic stages of the disease. Efforts to reach optimal benefit focus on the use of immune biomarkers prior to ICI therapy; unique combinations of ICIs and chemotherapy, radiotherapy, and tyrosine kinase inhibitors (TKIs); sequencing of ICI agents, treatment of duration of ICI therapy; and use of ICI agents stratified by patients' histopathology, sta

The first sign of skin cancer is usually a change in the skin, such as an emerging lump, a new mole, or alterations to an existing mole. Identifying any changes early can facilitate a prompt diagnosis of cancer, which may improve a person's outlook. There are many types of skin cancer, but they fall into two distinct categories: melanoma and non-melanoma. Melanoma is less common than non-melanoma but more dangerous. This article looks at several types of melanoma and non-melanoma skin cancers, what causes them, and how they appear on the skin. It also discusses how to reduce the risk of developing skin cancer. Skin cancer is the most common form of cancer in the United States. The Skin Cancer Foundation states that 1 in 5 people in the U.S. will develop skin cancer before the age of 70 years. When the skin becomes exposed to UV light, the rays can damage the DNA in its cells. Usually, this happens as a result of direct sunlight on bare skin. If this process damages certain genes

If your healthcare provider sees a suspicious mole during an exam, the next step is a skin biopsy. If that reveals melanoma, a pathologist will perform tests to determine how advanced the disease is—a process called staging. In addition, the thickness of the tumor is measured and assigned what's called a Breslow number. This figure has been found to be significant when coming up with a patient's prognosis. damiangretka/Getty images Once the stage and the Breslow number have been accurately determined, your healthcare provider can effectively plan your treatment. The TNM System In 2016, the American Joint Committee on Cancer (AJCC) released new guidelines for staging melanoma, known as the TNM system. Each letter of this name stands for a different aspect of a tumor's characteristics: T (tumor):  The important aspects of the tumor itself include how big it is, whether it has ulcerated (there is a breakdown of the skin over th

In the phase 3 IMforte clinical trial, researchers are exploring lurbinectedin and atezolizumab as induction and maintenance therapy for patients with extensive-stage small cell lung cancer. A clinical trial of the frontline combination of lurbinectedin (Zepzelca) and atezolizumab (Tecentriq) for the treatment of patients with extensive-stage small cell lung cancer (ES-SCLC) has enrolled its first subject, according to a press release by Jazz Pharmaceuticals. 1 "Small cell lung cancer can progress faster than most forms of lung cancer, although new treatment options can prolong life and improve long-term care options," said Luis Paz-Ares, MD, PhD, professor of medicine at Hospital Universitario 12 de Octubre in Madrid, Spain. "Jazz's collaborative research with Roche will provide much-needed insights into a potentially new small cell lung cancer therapeutic option in the first-line setting. With approximately a quarter million patients diagnosed glo

Excessive belching alone is not usually a sign of cancer. However, burping a lot and also experiencing pain, swelling, or other symptoms could be a sign of certain types of cancers that affect the gastrointestinal (GI) tract. Read more about the tie-in between excessive belching and cancer, a well as diagnosis, prevention, and treatment. Verywell / Joules Garcia What Causes Excessive Belching? Belching, also known as burping, is your body's way of expelling excess air from your upper digestive tract. According to a 2020 review, a healthy person burps up to 30 times a day. However, some conditions may cause you to burp more often. Most belching is caused by swallowing excess air. Eating or drinking too fast, talking while eating, drinking carbonated drinks, chewing gum, smoking, and having an anxiety attack (which can cause hyperventilation) can lead to excessive burping. Other causes of excessive belching include: Ga

YOUNGSTOWN, Ohio — A new analysis from the Mahoning County Auditor's office finds the Oakhill Renaissance place has cost the county nearly $25 million since 2006. Auditor: Oakhill Renaissance Place Still Bleeding Millions of County Dollars WRTA 'Holiday Lights' Campaign Brings Awareness to Nonprofits Mercy Health Hosts 'Movember' Shave Off Event Copyright 2021 The Business Journal, Youngstown, Ohio.

For many years, the prostate-specific antigen (PSA) test has been used to screen for prostate cancer. Although it promotes early detection of prostate cancer and has boosted survival rates, it has serious constraints. The test relies on establishing blood levels of PSA that are raised in prostate cancer patients. Since elevations in blood PSA can occur in a myriad of ways, the test is consequently non-specific for identifying prostate cancer and, therefore, is not infallible. Other, less severe prostate conditions, such as benign prostatic hyperplasia (BPH), prostatitis or prostate injury, as well as heavy exercise and ejaculation, can lead to the presentation of increased PSA levels. Therefore, a risk of false positives leads to patient anxiety and the unnecessary potential for overtreatment. There is also the possibility for false negatives as in 1 of 7 men with normal PSA levels diagnosed with prostate cancer. Furthermore, the PSA test does not show whether a patient has a h

Oncologists discuss a 59-year-old man with poorly differentiated adenocarcinoma of the lung. During a Targeted Oncology TM Case-Based Roundtable event, Mary Jo Fidler, MD, associate professor, Division of Hematology, Oncology, and Cell Therapy, Rush Medical College, discussed a 59-year-old man with non–small cell lung cancer. SHAH: I do next-generation sequencing [NGS] with FoundationOne CDx, as well as a Guardant [Health] liquid biopsy prior to initiating treatment. FIDLER: [Does] anyone else use both liquid biopsy and tissue biopsy at the same time? KAPLAN: Yes, I also do both at the same time, [using] Guardant liquid biopsy and then usually Caris [Life Sciences], unless an in-house [biopsy is] done. We'll do them simultaneously and usually get the [results of the] liquid biopsy first so we can see if there's an actionable mutation within a shorter period. KOKO: Usually, if the tissue is available, I will do FoundationOne testing with the tissue. I will only do the liquid bio